Fellowship Director, Gynecology Service; Director, Minimal Access and Robotic Surgery Program, Department of Surgery
I am a board-certified gynecologic oncologist who specializes in surgery for women with ovarian, endometrial, cervical, vulvar, or vaginal cancer.
I have a strong interest in providing minimally invasive surgical options for our patients, including both laparoscopic and robotic-assisted procedures. In 2006, I became one of the first gynecologic oncologists to use the da Vinci® Surgical System to perform robotically-assisted procedures in women with benign and malignant gynecologic conditions. Minimally invasive procedures result in less blood loss than do traditional surgeries, allowing for shorter hospital stays and faster recuperation time for patients. I serve as the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery at Memorial Sloan Kettering and have helped to build one of the best and most experienced robotic surgery programs in the world across multiple surgical specialties.
I also perform radical procedures via traditional laparotomy in cases when these more-traditional surgeries may provide better results and longer survival. These include debulking for ovarian cancer and radical procedures for other gynecologic cancers. Additionally, using the robotic approach, I perform fertility-sparing surgery (radical trachelectomy) for women with early-stage cervical cancer. I continue to seek ways to improve outcomes for my patients and continuously seek to evaluate cutting edge technologies in surgery.
I also have a strong interest in clinical research. Research is vital for development of better treatments for all patients diagnosed with cancer. People with cancer face a difficult journey, and clinical trials are just one of the tools I offer my patients to help them during this time. I serve as the principal investigator at Memorial Sloan Kettering for the Gynecologic Oncology Group — a national group conducting quality cooperative research at many institutions throughout the country.
In 2004, I completed my fellowship at Memorial Sloan Kettering and received the Michael E. Burt Memorial Award for Clinical Excellence. I then became Director of Gynecologic Services at the New Jersey Medical School, where I received the National Faculty Award from the Council on Resident Education in Obstetrics and Gynecology. I joined the Memorial Sloan Kettering staff in 2007. I am a member of many medical societies and the author of peer-reviewed scientific articles, chapters, and reviews.
I am at the Main Campus in Manhattan Monday through Thursday, and I see patients every Friday at our Basking Ridge, New Jersey, location.
- Clinical Expertise: Minimally invasive procedures (including robotics) for patients with gynecologic malignancies and other complex benign gynecologic conditions; fertility-sparing radical trachelectomy using minimally invasive surgery or robotics; uterine sarcomas; other gynecologic malignancies
- Languages Spoken: English
- Education: MD, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School
- Residencies: Beth Israel Medical Center (New York)
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Obstetrics and Gynecology; Gynecologic Oncology
Leitao Jr. MM. Goldsmtih LT. Optimal study design and the CONSORT guidelines. (letter) Fertil Steril 2005;84:105
Leitao Jr., MM, Chi DS. Fertility-sparing options for patients with gynecologic malignancies. The Oncologist 2005;10:613-22. CME activity
Leitao Jr. MM, Chi DS. Cytoreductiv surgery for ovarian cancer. Postgraduate obstetrics and Gynecology 2004;24(10): 1-8. CME activity
Leitao Jr. MM, Barakat RR. Medical therapy for endometrial hyperplasia and early endometrial cancer in patients desiring future childbearing. In Angioli R, Panici B., Kavanagh D, Pecorelli S., Penalver M (eds): chemotherapy for Gynecologic Neoplasms: current Therapy and Novem Approaches, 1st ed, 2004:507-517.
Hensley ML, Leitao Jr. MM, Brown CL. Management of early epithelial ovarian cancer. In: Markman M (ed). Atlas of Cancer. Phhiladelphia, PA: Current Science, 2003:87-91
Leitao Jr., MM, Hoskins WJ. Surgical cytoreductin. In: Levine DA, Barakat RR, Hosking WJ (eds): Atlas of Procedures in Gynecologic Oncology, 1st ed, 2003:45-80.
Leitao Jr. MM, Brown C. Radical abdominal hysterectomy. In: Levine DA, Barakat RR, Hoskins WJ (eds): Atlas of procedures in Gynecologic Oncology, 1st ed, 2003:33-44
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Mario M. Leitao, Jr.
- A Phase II Study of Paclitaxel/Carboplatin versus Bleomycin/Etoposide/Cisplatin for Patients with Advanced Ovarian Stromal Tumors Who Have Not Received Chemotherapy
- A Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Patients with Intermediate-Risk, Stage I/IIA Cervical Cancer Treated with Surgery
- A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Cancer Following Radical Hysterectomy
- A Phase III Study Assessing Chemoradiation Alone and with Additional Chemotherapy in Women with Locally Advanced, Inoperable Cervical Cancer: The OUTBACK Trial
- Evaluation of Physical Function and Quality of Life Before and After Non-Radical Surgery for Stage I Cervical Cancer
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more